RN7SL32P

Across TCGA pan-cancer cohorts, RN7SL32P RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RN7SL32P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RN7SL32P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RN7SL32P expression acts as an unfavorable survival marker, although some lineages such as HNSC and STAD show a favorable association.

HNSC, COAD, and STAD are the cancer types where RN7SL32P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.852	0.715	.001	67	view →
COAD	OS	Tertile	All	0.684	0.894	.001	28	view →
STAD	OS	Median	IV	0.696	0.205	.005	21	view →
THYM	DFS	Median	All	0.923	0.808	.018	9	view →
SKCM	DFS	Tertile	All	0.277	0.190	.023	8	view →
CESC	DFS	Tertile	All	0.687	0.411	.021	8	view →
ACC	DFS	Tertile	All	0.552	0.846	.009	7	view →
OV	OS	Median	III,IV	0.719	0.645	.034	6	view →
MESO	OS	Tertile	IV	0.307	0.621	.036	6	view →
LIHC	DFS	Median	All	0.509	0.319	.010	6	view →
KIRC	DFS	Quartile	IV	0.180	0.364	.034	4	view →
KIRP	DFS	Median	II,III,IV	0.902	0.403	.034	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RN7SL32P–HNSC (OS)

Open the HNSC breakdown →